Genomic evidence of HMPV resurgence in Beijing: Clade B2 triggers the 2024 winter epidemic peak
Authors:
Open Access
- 1 February 2026
- journal article
- Published by KEAI Publishing in Virologica Sinica
- Vol. 41 (1) , 48-57
Abstract
With an unexpected increase of human metapneumovirus (hMPV) cases in northern China since late 2024, concerns arose whether novel hMPV variants triggered this epidemic. Utilizing the Beijing Respiratory Pathogen Surveillance System (RPSS), we conducted a genomic evolutionary analysis spanning 2014-2024 and revealed genetic information for the strains that caused the high rates of hMPV outbreaks during this period. To clarify the epidemic drivers and evolutionary characteristics of the hMPV strains circulating in Beijing, phylogenetic, population dynamic and mutation analyses were performed using high-quality complete sequences from both this study and publicly available data. A total of 348 high-quality hMPV genomes were obtained by next-generation sequencing (NGS), all of which belonged to four known clades: A2b1, A2b2, B1, and B2. Before 2024, A2b2 predominated in Beijing; however, a shift to clade B2 was observed starting in late 2024. In addition, a phylogenetically independent lineage Ⅰ was identified in this study, accounting for 93.1% of B2 genomes collected since late 2024. Furthermore, we identified several unique nonsynonymous mutations in viruses within lineage I that may have phenotypic implications. Our findings indicate that lineage I of clade B2 was the major cause of the unusual increase in hMPV outbreaks in Beijing in late 2024, with no evidence of an emerging novel variant. Although our data were only restricted to samples from Beijing, the findings are likely representative of the hMPV surge across northern China in 2024, given city's high population density and mobility.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFF1203203)
- Beijing Municipal Health Commission (2024-1G-3015)
- Beijing Municipal Health Commission (L242051)
- Natural Science Foundation of Beijing Municipality
- Ministry of Science and Technology of the People's Republic of China (2022FY100903)
This publication has 53 references indexed in Scilit:
- A brief history of human infections with H5Ny avian influenza virusesCell Host & Microbe, 2025
- Genome sequencing reveals molecular epidemiological characteristics and new recombinations of adenovirus in Beijing, China, 2014−2019Journal of Medical Virology, 2023
- Status and challenges of global antimicrobial resistance control: A dialogue between Professors Yonghong Xiao and Takeshi NishijimahLife, 2023
- Global public health crisis response: A roundtable discussion with Professor George Fu Gao, Professor Jules A Hoffmann, Professor Chris Walzer and Professor Jiahai LuhLife, 2023
- Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition modeCell Host & Microbe, 2023
- Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individualshLife, 2023
- Report of death in children with SARS‐CoV‐2 and human metapneumovirus (hMPV) coinfection: Is hMPV the trigger?Journal of Medical Virology, 2020
- From “A”IV to “Z”IKV: Attacks from Emerging and Re-emerging PathogensCell, 2018
- Human respiratory syncytial virus load normalized by cell quantification as predictor of acute respiratory tract infectionJournal of Medical Virology, 2018
- Clinical impact of human metapneumovirus genotypes and genotype‐specific seroprevalence in Yamagata, JapanJournal of Medical Virology, 2008